It could be noted that the mRNA expression of CD95 was increased by 11-fold, while CD95L was enhanced by only 1.4-fold upon gemcitabine treatment (20 μM) compared to the untreated (saline control-0.9%NaCl) pancreatic tumor cell line PancTuI-luc (Figure 2A). The gene discussed is FAS; the disease is pancreatic neoplasm.